White House withdraws Heidi Overton's FDA nomination a day before Senate panel vote
The agency that approves drugs and vaccines may stay under an acting chief through its decision on the abortion pill, due by March.
Trump signs his August order on childhood vaccines, which called for splitting up the MMR shot; Cassidy faulted Overton for supporting the plan. Photo, August 2026: Molly Riley / The White House / Public domain
Who covered this
On this page · sections
The short version
- The White House pulled Dr. Heidi Overton's nomination to lead the FDA on Tuesday, a day before a Senate committee vote.
- The agency that approves drugs and vaccines stays under an acting chief as it reviews the abortion pill mifepristone.
- No new nominee has been named, and Democrats take control of the Senate in January.
Documents in this story · 3
- RecordExecutive session on nominationsSenate HELP Committee · Web page · Nov. 18Open Archived
- RecordNomination hearing of Heidi Overton to be Commissioner of Food and DrugsSenate HELP Committee · Web page · Sept. 24Open Archived
- Statute5 U.S.C. 3346, time limitation for acting officers (Cornell LII)U.S. Code · Web pageOpen Archived
The White House withdrew Dr. Heidi Overton's nomination to lead the Food and Drug Administration on Tuesday evening, a day before a Senate committee vote, a White House official confirmed.
The move leaves the agency that approves the country's drugs and vaccines without a confirmed leader, possibly for months. The FDA has had no permanent chief since Dr. Marty Makary resigned in May. Kyle Diamantas, an attorney who was the agency's top food official, has run it on an acting basis since then. And Democrats take control of the Senate in January.
Two accounts of why the Overton nomination ended
The White House and the Republican who chairs the committee gave different reasons. A senior White House official told Axios that Overton "lacks the support on the Hill to move forward with her confirmation." Three people familiar with the matter told Reuters the same thing: there was not enough support in Congress. No named White House spokesperson has given a reason.
Sen. Bill Cassidy of Louisiana, the committee's chairman, said the votes were there. "Tonight, the White House abandoned a viable confirmation path for Dr. Overton," he wrote on X. Senators who oppose abortion had asked for final assurances on the administration's commitment to their issues, he said, and the White House withdrew her instead. He said he believed she would have cleared both the committee and the full Senate. With so little time left, he added, "confirming a permanent FDA Commissioner will fall to Senate Democrats."
That account matters because Cassidy had raised doubts about her himself. He called her support for President Donald Trump's plan to split up the combined measles, mumps and rubella shot "almost disqualifying." As late as Sunday, he would not say how he would vote. Two sources told CBS News the White House shared its decision on Tuesday evening, while efforts to round up Republican votes were still underway.
We found no public response from Overton as of 11:50 p.m. ET Tuesday. In August, when he picked her, Trump called her a "ROCKSTAR."
How the committee votes stacked up
The math left no room. Republicans hold a one-vote majority on the Health, Education, Labor and Pensions Committee, so one Republican "no" would sink her if every Democrat voted against her. Sens. Susan Collins of Maine and Lisa Murkowski of Alaska had not said how they would vote.
Her troubles came from several directions. Overton, a preventive medicine doctor, is deputy director of the White House Domestic Policy Council and was chief policy officer at the America First Policy Institute, a conservative think tank. At her Sept. 24 hearing, she told Cassidy the MMR vaccine is safe and effective, Fox News reported, but she would not say whether Trump was wrong about it. She also defended the FDA's May authorization of fruit-flavored vapes, and an advocacy group, Health in Office, put up posters across Washington against her. The signs branded her "Heidi Vaperton."
Abortion cut both ways. Overton called the end of Roe v. Wade "a huge victory for life," yet at her hearing she would not say directly whether she believes the abortion pill mifepristone is safe. Murkowski pressed her on political pressure over access to the pill. On the other side, SBA Pro-Life America said the next nominee should commit to ending mail-order access to abortion pills.
Supporters of Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" movement also opposed her. They blamed her and other White House aides for sidelining Kennedy's goals on food additives and pesticides.
What the vacancy means for the FDA's mifepristone review
The FDA says its safety review of mifepristone will conclude by March 2027. A new nominee would need a hearing and a vote in the few weeks Republicans have left in charge of the Senate. So the decision on the pill may well come under an acting leader.
The law sets how long an acting leader can stay. Under the Federal Vacancies Reform Act, acting officials are limited to about seven months. But the statute's own text adds a reset: when a first nomination is withdrawn, the acting officer may keep serving for 210 more days from the date of the withdrawal. Counted from this week, that would let an acting chief serve to about mid-June 2027, past the mifepristone deadline. A second nomination would extend it again, for as long as that nomination is pending.
Confirming a permanent FDA Commissioner will fall to Senate Democrats.
Who the next nominee might be is open. Two people told Reuters the White House is weighing Sen. Roger Marshall of Kansas, a former obstetrician who lost his reelection bid this month. The White House had also talked with people who could serve as acting commissioner without Senate confirmation, CBS News reported.
What we don't know yet
It is not clear when, or if, the White House will name another nominee, or whether that person would face this committee or a Democratic one.
We also don't know the date of the formal withdrawal, which starts the 210-day clock. The committee's notice for its 9:45 a.m. Wednesday session still listed Overton late Tuesday. Nor do we know whether Overton, or a named White House official, will explain the decision or answer Cassidy's account.
Sources
Left
9 of 13 left-leaning outlets we track reported this
- NBC News: White House drops Heidi Overton's FDA nomination, Nov. 17
- CBS News: White House drops Heidi Overton's nomination for FDA commissioner, Nov. 17
- CBS News: Trump FDA nominee Heidi Overton struggling to win enough GOP support to be confirmed, Nov. 17
- AP: White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans, Nov. 17
Center
3 of 9 center outlets we track reported this
Right
4 of 12 right-leaning outlets we track reported this
- Fox News: White House pulls Trump's FDA pick Heidi Overton on eve of Senate panel vote, Nov. 17
- New York Post: White House withdraws Heidi Overton's FDA nomination after Trump pick received bipartisan pushback, Nov. 17
- The National Desk: White House pulls Heidi Overton's FDA nomination amid GOP opposition, Nov. 17
Primary
This article was produced by AI under our Editorial Standards. Corrections are reviewed before they go live.
How coverage differs
Free with a Fair Witness account
See how left, center and right covered this story
A free account shows where the coverage agrees and where it splits, what each side played up and played down, and, when one side's outlets missed a story, who missed it.
Keep reading
The newest stories in Health, then the rest of the site.
Newest · Health
US loses measles elimination status after 26 years, PAHO says
The finding that measles spreads here again means the U.S. must now stop the spread for a full year to win the status back.
Latest
New stories and updates, newest first. Times are Eastern.
-
Nov 18
2:55 PMUpdated World
Part of Crimean Bridge collapses after Ukrainian strike as Russia hits Kyiv's bridges
Each side hit bridges it calls military routes, two days before Trump meets Putin and Xi in China.
-
Nov 18
11:14 AMUpdated World
Trump will meet Xi and Putin together Thursday to discuss nuclear arms, White House says
No treaty has capped the world's two largest nuclear arsenals since February, and Trump wants China in whatever replaces it.
-
Nov 18
11:14 AMUpdated U.S.
NSA's classified network goes down; White House says no sign of a cyberattack
The intelligence agency's internal system for sharing secrets failed in a week of U.S. tech outages, and Democrats want a briefing.
-
Nov 18
11:14 AMUpdated Technology
Apple outage: company says an internal update hit iCloud, Apple Pay and App Store
Many services were back by afternoon, but Apple's status page for app makers still listed key tools as down Tuesday evening.
-
Nov 18
9:15 AMNew Culture
Pope Leo says no to married priests for now, details his lung cancer surgery
His answer keeps on hold a 2019 proposal from Amazon bishops to make married deacons priests where communities wait years for one.
-
Nov 18
2:16 PMUpdated U.S.
Mullin defends flying government plane to LSU-Texas game a day after FAA ground stop
His department says he paid his way, but federal rules can set that at a coach fare, and no one has said what he paid.
-
Nov 18
2:15 PMUpdated World
Iran fires on U.S. air base in Kuwait and at Bahrain after U.S. strike on Qeshm
Iran's first attack on Kuwait in two months widens a weeklong exchange of fire, and Washington has not said how it will answer.
-
Nov 18
12:41 PMNew World
Britain hands Army officer accused of spying for Russia to U.S. military
The handover moves any prosecution to the United States, where officials have not said whether a military or civilian court would hear it.
Edge of Frame · Right
-
Nov 18
12:30 PMTop story U.S.
Garcia tells Vance, Trump's sons and others to preserve records for House probes
The letters map what Democrats plan to investigate once they take the House in January and gain the power to subpoena.
-
Nov 18
12:25 PMTop story U.S.
House Democrats nominate Hakeem Jeffries for speaker, 251-11, ahead of Jan. 3 vote
Eleven Democrats voted no in a count he asked for. His party's projected majority lets him lose almost 40 votes and still reach 218.
-
Nov 18
11:53 AMUpdated World
US Army soldier arrested in UK on suspicion of spying for Russia
The soldier, who has not been named or charged, was assigned to a NATO headquarters built to respond quickly to crises.
-
Nov 18
11:40 AMUpdated World
U.S. strikes Iran's Qeshm Island after third Iranian attack on Bahrain, officials say
It is the U.S. reply to Iranian attacks that ended a two-month lull, and Iran's next move will show whether the exchange keeps going.
-
Nov 18
11:39 AMUpdated U.S.
White House counsel warns Oversight Democrats their probes could be criminal
The letter escalates a fight over how far Congress can dig into the Trump administration once Democrats take over in January.
The Fair Witness Daily
Get each morning's Spin Meter in your inbox
The Daily leads with the Spin Meter, then the day's explainers. A free account also unlocks every Spin Meter on the site.
Free. Unsubscribe anytime. Already a member? Sign in